Steps Forward for the PALLAS Reactor NRG PALLAS (ENS Corporate Member) announced the completion of the construction pit and the foundation, marking the end of this phase of the PALLAS project. This has laid the foundation for the next phase of construction. The arrival of the PALLAS-reactor is crucial for the production of medical isotopes.…
NRG PALLAS and Curium Sustain Continuity in the Global Supply of Mo-99 NRG PALLAS (ENS Corporate Member) and Curium have recently extended their collaboration for the production of molybdenum-99, which decays into technetium-99m, through a new multi-year agreement, essential to ensure the continuity of medical isotope supply. This agreement underlines the shared dedication of both partners…
PRESS RELEASE ENS High Scientific Council Briefing Paper Unlocking the Potential of Radiopharmaceuticals in Europe – Part 1: Setting the Scene Brussels, 18th March 2026 — The European Nuclear Society High Scientific Council (HSC) has published a new Briefing Paper titled “Unlocking the Potential of Radiopharmaceuticals in Europe – Part 1: Setting the Scene”, providing…
BR2 Research Reactor Sets A New Production Record, Helping 13 Million Patients in 2025 The Belgian Nuclear Research Centre SCK CEN (ENS Corporate Member) announced that the production of medical radioisotopes at its BR2 research reactor supported 13 million patients worldwide in 2025, setting a new record in the facility’s history. “It shows that we…